Skip to main content

Diagnostic options Β· UAE

Genetic Sequencing tests in Dubai & UAE

Compare available Genetic Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

256

Listed price range

2,600.00–5,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Sequencing test prices

Showing 121–135 of 256 matching tests.

Genetic Sequencing diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-2865
HMG20B Gene Dysmorphism Genetic Test

This genetic test evaluates the HMG20B gene for sequence variants linked to congenital anomaly syndromes and neurodevelopmental disorders.

Peripheral whole blood in EDTA, extracted DNA, or validated FTA card 3–4 weeks (expedited options available) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Sequence variants in the HMG20B gene", "Causative variants linked to pediatric dysmorphology"]
Parameters
[]
Preparation
[]
Indications
["Patients with unexplained dysmorphic features", "Individuals with neurodevelopmental delay", "Family screening following confirmed pathogenic variant in proband"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81317-0 ICD-10: Q87.8
Clinical summary
This genetic test evaluates the HMG20B gene for sequence variants linked to congenital anomaly syndromes and neurodevelopmental disorders.
TEST-2209
HOXD13 Gene VATER Association Genetic Test

This test evaluates the HOXD13 gene for pathogenic variants associated with VATER association and related limb malformations.

Whole Blood (EDTA), FTA Card, or Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the HOXD13 gene", "Exons and intron boundaries of HOXD13"]
Parameters
[]
Preparation
["No fasting or special preparation is required"]
Indications
["Infants and children with features of VATER association", "Individuals with syndromic limb malformations"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94100-6 ICD-10: Q87.2
Clinical summary
This test evaluates the HOXD13 gene for pathogenic variants associated with VATER association and related limb malformations.
TEST-5459
HR Gene Alopecia Universalis Genetic Test

This test identifies pathogenic variants in the HR gene associated with Alopecia Universalis and Atrichia with Papular Lesions.

Whole Blood, Extracted DNA, or FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the HR gene"]
Parameters
[]
Preparation
["No specific dietary or drug avoidance required", "Do not alter existing medication without physician instruction"]
Indications
["Individuals with early-onset total scalp and body hair loss", "Suggestive family history", "Clinical features of atrichia with papular lesions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 50397-9 ICD-10: L63.8
Clinical summary
This test identifies pathogenic variants in the HR gene associated with Alopecia Universalis and Atrichia with Papular Lesions.
TEST-4231
HSPG2 Gene Dyssegmental Dysplasia, Silverman-Handmaker Type Genetic Test

This genetic test identifies pathogenic variants within the HSPG2 gene, confirming the diagnosis of Dyssegmental Dysplasia, Silverman-Handmaker Type.

Peripheral Whole Blood, DNA FTA Card, Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["HSPG2 gene coding region variants", "Perlecan protein stability"]
Parameters
[]
Preparation
["Avoid blood transfusion or platelet-rich plasma therapy within 14 days", "Postpone test if active systemic infection requiring IV antibiotics"]
Indications
["Suspected diagnosis of Dyssegmental Dysplasia, Silverman-Handmaker Type", "Family history of the disorder", "Recurrence risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94120-2 ICD-10: Q77.8
Clinical summary
This genetic test identifies pathogenic variants within the HSPG2 gene, confirming the diagnosis of Dyssegmental Dysplasia, Silverman-Handmaker Type.
TEST-2313
IFT172 Gene Short-Rib Thoracic Dysplasia Type 10 with or without Polydactyly Genetic Test

This test evaluates the IFT172 gene for pathogenic variants associated with Short-Rib Thoracic Dysplasia Type 10 (SRTD10). It identifies genetic mutations causing this rare skeleta...

Peripheral Whole Blood (EDTA) or Buccal Swab (neonates) 3–4 weeks (expedited available) 2,800.00 AED
View
View test specifications and preparation
What it measures
["IFT172 gene coding regions", "IFT172 gene splice junctions"]
Parameters
[]
Preparation
["No fasting required", "Inform lab of any relevant clinical history"]
Indications
["Neonates and children with suspected SRTD10", "Patients presenting with short ribs, narrow thorax, and polydactyly"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94035-0 ICD-10: Q77.2, Q87.0
Clinical summary
This test evaluates the IFT172 gene for pathogenic variants associated with Short-Rib Thoracic Dysplasia Type 10 (SRTD10). It identifies genetic mutations causing this rare skeletal disorder.
TEST-5219
IKBKG Gene Ectodermal Dysplasia, Hypohidrotic, with Immune Deficiency Genetic Test

This genetic test identifies mutations in the IKBKG gene associated with X-linked hypohidrotic ectodermal dysplasia with immune deficiency.

Peripheral whole blood (EDTA) or FTA card dried blood spot 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["IKBKG gene mutations", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Suspected X-linked hypohidrotic ectodermal dysplasia with immune deficiency", "Family history of EDA-ID", "Recurrent infections with ectodermal features"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 58000-6 ICD-10: Q82.4, D84.9
Clinical summary
This genetic test identifies mutations in the IKBKG gene associated with X-linked hypohidrotic ectodermal dysplasia with immune deficiency.
TEST-5386
IKBKG Gene Genetic Test for Atypical Mycobacterial Infection Susceptibility

This test evaluates the IKBKG (NEMO) gene for pathogenic variants associated with primary immunodeficiency and susceptibility to atypical mycobacterial infections.

Peripheral Whole Blood, FTA Card, or Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the IKBKG (NEMO) gene", "Copy Number Variations (CNVs) in the IKBKG gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of current medications"]
Indications
["Suspected primary immunodeficiency", "Suspected anhidrotic ectodermal dysplasia (EDA-ID)", "Recurrent atypical mycobacterial infections", "Family history of X-linked immunodeficiency"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92848-8 ICD-10: D84.8, A31.0
Clinical summary
This test evaluates the IKBKG (NEMO) gene for pathogenic variants associated with primary immunodeficiency and susceptibility to atypical mycobacterial infections.
TEST-4864
IRAK4 Deficiency Genetic Test

This test detects pathogenic variants in the IRAK4 gene using Next-Generation Sequencing (NGS). It identifies single-nucleotide variants, small insertions/deletions, and copy-numbe...

Whole Blood (Venipuncture or FTA Card Dried Blood Spot) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the IRAK4 gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number alterations"]
Parameters
[]
Preparation
[]
Indications
["Patients presenting with recurrent pyogenic infections", "Suspected autosomal recessive primary immunodeficiency"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: D82.9
Clinical summary
This test detects pathogenic variants in the IRAK4 gene using Next-Generation Sequencing (NGS). It identifies single-nucleotide variants, small insertions/deletions, and copy-number alterations associated with IRAK4 deficiency.
TEST-3247
ITK Gene Lymphoproliferative Syndrome Type 1 Genetic Test

This test identifies pathogenic variants within the ITK gene associated with Lymphoproliferative Syndrome Type 1 (LPFS1), a primary immunodeficiency.

Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ITK gene pathogenic variants", "Loss-of-function mutations in ITK"]
Parameters
[]
Preparation
["No fasting required", "Detailed clinical history documenting lymphoproliferative symptoms required", "Mandatory genetic counselling session required"]
Indications
["Suspected Lymphoproliferative Syndrome Type 1", "Family history of ITK-related immunodeficiency", "Evaluation of combined immunodeficiency"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 60215-0 ICD-10: D47.9
Clinical summary
This test identifies pathogenic variants within the ITK gene associated with Lymphoproliferative Syndrome Type 1 (LPFS1), a primary immunodeficiency.
TEST-5681
KCNQ2 Gene Sequencing (Benign Familial Neonatal Seizures Type 1) Test

This test evaluates the KCNQ2 gene for mutations associated with benign familial neonatal seizures type 1 (BFNS1).

Whole Blood (EDTA), Buccal Swab, or FTA Card Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["KCNQ2 gene coding regions", "KCNQ2 gene splice sites", "Large deletions/duplications in KCNQ2"]
Parameters
[]
Preparation
["Parental or legal guardian consent is mandatory for all minors.", "A formal genetic counseling session must be completed prior to sample collection."]
Indications
["Infants with clinical suspicion of KCNQ2-related neonatal epilepsy", "Documented family history of benign familial neonatal seizures"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94218-6 ICD-10: G40.3
Clinical summary
This test evaluates the KCNQ2 gene for mutations associated with benign familial neonatal seizures type 1 (BFNS1).
TEST-4611
KDM6A Gene (Kabuki Syndrome Type 2) DNA Test

This test identifies pathogenic variants in the KDM6A gene, which are associated with Kabuki syndrome type 2.

Whole Blood (5 mL in EDTA), Extracted DNA, or FTA Card Blood Spot 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the KDM6A gene", "Copy Number Variants (CNVs) in the KDM6A gene"]
Parameters
[]
Preparation
["A detailed pre-test genetic counselling session is mandatory.", "Informed consent must be signed by the patient or legal guardian."]
Indications
["Individuals with clinical features of Kabuki syndrome", "Family history of Kabuki syndrome", "Children with suspected congenital syndromes", "Adults with undiagnosed neurodevelopmental disorders", "Family planning when a known KDM6A mutation exists"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48002-0 ICD-10: Q87.0
Clinical summary
This test identifies pathogenic variants in the KDM6A gene, which are associated with Kabuki syndrome type 2.
TEST-6303
KHK Gene (Essential Fructosuria) Genetic Test

This test evaluates the KHK gene for variants associated with Essential Fructosuria, a benign metabolic condition.

Whole Blood (EDTA), FTA Card, or Extracted Genomic DNA 3–4 Weeks (Express available) 2,800.00 AED
View
View test specifications and preparation
What it measures
["KHK gene coding region", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"]
Parameters
[]
Preparation
["No fasting or special preparation required"]
Indications
["Routine urinalysis reveals reducing substances", "Family history of the condition", "Differentiation from Hereditary Fructose Intolerance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101379-3 ICD-10: E74.12
Clinical summary
This test evaluates the KHK gene for variants associated with Essential Fructosuria, a benign metabolic condition.
TEST-4981
KPTN Gene Intellectual Disability (MRD41) Genetic Test

This test identifies pathogenic variants in the KPTN gene associated with autosomal recessive intellectual disability type 41 (MRD41). It uses next-generation sequencing (NGS) for...

Peripheral whole blood or FTA card spot 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in KPTN gene", "Point mutations", "Small indels"]
Parameters
[]
Preparation
[]
Indications
["Unexplained developmental delay", "Suspected intellectual disability type 41 (MRD41)", "Macrocephaly", "Characteristic facial dysmorphism"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82939-0 ICD-10: F78.9, F70
Clinical summary
This test identifies pathogenic variants in the KPTN gene associated with autosomal recessive intellectual disability type 41 (MRD41). It uses next-generation sequencing (NGS) for high diagnostic sensitivity.
TEST-2495
KRAS Gene Noonan Syndrome Type 3 Genetic Test

This test identifies pathogenic variants within the KRAS gene, which are associated with Noonan syndrome type 3 and related RASopathies.

Peripheral Blood (EDTA) or Dried Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the KRAS gene"]
Parameters
[]
Preparation
["No fasting required"]
Indications
["Clinical suspicion of Noonan syndrome type 3", "Evaluation of dysmorphology", "Genetic counselling for RASopathies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 91699-4 ICD-10: Q87.1
Clinical summary
This test identifies pathogenic variants within the KRAS gene, which are associated with Noonan syndrome type 3 and related RASopathies.
TEST-4381
KRAS Gene Sequencing for Cardiofaciocutaneous Syndrome (Genetic Test)

This test identifies pathogenic variants in the KRAS gene associated with Cardiofaciocutaneous Syndrome.

Peripheral Whole Blood or Extracted DNA (saliva acceptable with prior approval) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the KRAS gene"]
Parameters
[]
Preparation
[]
Indications
["Individuals with a family history of Cardiofaciocutaneous Syndrome", "Individuals presenting with symptoms suggestive of the syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 98734-8 ICD-10: Q87.89
Clinical summary
This test identifies pathogenic variants in the KRAS gene associated with Cardiofaciocutaneous Syndrome.

Category overview

Genetic Sequencing: overview

Achieving a definitive diagnosis for multi-system or exceptionally rare disorders requires reading the deepest layers of your foundational biological code. As the pinnacle of our advanced Genetics department, Genetic Sequencing (including Whole Exome or Whole Genome testing) provides an incredibly detailed, high-resolution scan of your DNA. By leveraging state-of-the-art Next-Generation Sequencing technology, this expansive molecular screening helps uncover elusive genetic variants that standard tests miss, safely guiding your healthcare provider in tailoring highly personalized medical treatments and opening doors to advanced precision medicine. Consistently trusted for advanced genomic analysis across premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, exceptional analytical precision, and highly efficient reporting. Secure the definitive insights your health requiresβ€”book your genetic sequencing testing in UAE, arrange a secure clinical sample collection, or consult our dedicated medical genetics experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.